Suggestions
Pascal Levensohn
Venture Capitalist
Pascal Levensohn is a seasoned venture capitalist and investment professional with over four decades of business experience. He currently serves as a Board Observer at Salvia BioElectronics, a Netherlands-based company.12
Professional Background
Levensohn joined Dolby Family Ventures, L.P. in 2014, where he currently manages over 80 early-stage portfolio company investments across various sectors, including augmented reality, aerospace, materials sciences, and biotech.1 He is also the founder and Managing Partner of Levensohn Venture Partners LLC (LVP) and the CEO of Levensohn Global LLC (LG).1
Board Positions
In addition to his role at Salvia BioElectronics, Pascal Levensohn holds several other notable board positions:
- Chairman of the Board at SoundThinking, Inc. (NASDAQ
) - Chairman of the board at NativeWaves GmbH (Salzburg, Austria)
- Director at Cure Network Dolby Acceleration Partners LLC (CNDAP)
- Board Observer at Okapi
(Germany)1
Expertise and Contributions
Levensohn is recognized for his expertise in corporate governance, having published three widely read white papers on the topic since 1999.1 His experience includes serving as board chairman, audit committee chairman, compensation committee chairman, and board secretary for venture-backed companies since 1996.1
Education and Affiliations
Pascal Levensohn holds an AB in Government, cum laude, from Harvard University. He is a life member of the Council on Foreign Relations and has been involved with various prestigious organizations:
- Former director of the National Venture Capital Association (2007-2011)
- Former faculty member of the Kauffman Fellows Program Center for Venture Education (2006-2020)
- Former co-chairman of the Socrates Society Forum of the Aspen Institute (2007-2009)
- Former Chairman of the San Francisco Jewish Community Federation's Business Leadership Council (2007-2008)1
With his extensive experience and diverse board positions, Pascal Levensohn brings valuable insights and expertise to his role as Board Observer at Salvia BioElectronics.
